Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06474611 · ClinicalTrials.gov registry record · NA
Evaluation of a Patient 'nudge' on Engagement in Lung Cancer Screening
A NA study of Lung Cancer, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 894
- Enrollment target
- 1
- Study location
NCT06474611: Completed NA study of Lung Cancer, sponsored by Kaiser Permanente.
NCT06474611 is a NA study of Lung Cancer that has completed, run by Kaiser Permanente. The registered enrollment target is 894 participants, roughly in line with the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06474611, a NA study of Lung Cancer, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 894 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this quality improvement project is to conduct and evaluate the effect of sending an electronic reminder message to patients who qualify for lung cancer screening, haven't had a screening previously, and who have an upcoming scheduled appointment with their doctor.
Primary Outcome
The proportion completed a visit with a Primary Care provider by receipt of an electronic letter or paper letter
Conditions Studied
Interventions
- BEHAVIORAL Patient nudge
Study Locations (1)
Colorado
- Kaiser Permanente - Aurora
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 894 participants |
| Start Date | 2024-03-26 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
What the finished NCT06474611 record still lists
NCT06474611 is an interventional study that assigns participants to a tested intervention. The registered 894 participants enrollment target is mid-sized for trials with a published cap, roughly in line with the 934-participant average among 409 other Lung Cancer trials with a reported enrollment target.
The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 1 intervention - of which Patient nudge is the first listed.
NCT06474611 reports a single indexed study location in Colorado.
Frequently Asked Questions
What is clinical trial NCT06474611 about?
NCT06474611 is a clinical study titled "Evaluation of a Patient 'nudge' on Engagement in Lung Cancer Screening". The purpose of this quality improvement project is to conduct and evaluate the effect of sending an electronic reminder message to patients who qualify for lung cancer screening, haven't had a screening previously, and who have an upcoming scheduled appointment with their doctor.
What is the current status of trial NCT06474611?
This trial is currently completed. It is a NA study. The enrollment target is 894 participants. The study started on 2024-03-26. Estimated completion is 2024-12-31.
What conditions does trial NCT06474611 study?
This clinical trial studies the following conditions: Lung Cancer.
What interventions are being tested in trial NCT06474611?
The interventions under investigation include: Patient nudge (BEHAVIORAL).
Who is sponsoring clinical trial NCT06474611?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06474611 being conducted?
This trial has 1 study location across Colorado. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lung Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT06474611's enrollment target sits among peer trials
894 53rd of 409 higher than 357 of 409 other Lung Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Lung B.A.S.E.S. 4 Life Mobile Low-dose Computed Tomography (LDCT) Screening: Ages 40-54
RECRUITING · NA
-
Lung Cancer Screening in High-risk Black Individuals
RECRUITING · NA
-
A Patient and Provider Intervention to Address Health Disparities in Lung Cancer Screening
RECRUITING · NA
-
Exercise as Maintenance Therapy in Advanced Lung Cancer
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Stereotactic Magnetic Resonance Guided Radiation Therapy
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04862663 · 895 participants · Phase 3
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
- NCT05855200 · 892 participants · Phase 3
Study of Perioperative Dostarlimab in Participants With Untreated T4N0 or Stage III dMMR/MSI-H Resectable Colon Cancer
- NCT03564340 · 890 participants · Phase 1
Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers
- NCT02352116 · 900 participants · NA
Evaluation of Post-PACU Pain Management in Pediatric Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI